Jorge Celaya

CFO Jorge Celaya sells 22,721 shares at blended avg $35.74 for $812,152.87; retains 66,895 shares plus 72,700 derivative holdings

Jorge Celaya executed 7 separate sales totaling 22,721 shares for $812,152.87 across three trading days (May 26–28, 2026), reducing his non-derivative holdings by 25.4%. The blended average transaction price of $35.74 sits slightly below the current price of $36.33 and is 6.4% below the 52-week high of $38.83. At the same-ticker level, Celaya's 5 prior sales at LQDT show mixed timing outcomes: 3 were well-timed (90-day declines), but 2 were poorly timed (90-day gains of +1.0% and +3.0% respectively). His 30-day returns after prior LQDT sells ranged from +4.8% to -15.6%, showing no consistent directional pattern. The company's fundamentals remain solid—revenue growth of +31.2% year-over-year and a strong quarterly net income of $7,522,000—though the P/E of 37.45 reflects elevated valuation expectations. Celaya retains substantial economic exposure through derivative securities totaling 72,700 shares across five option grants, suggesting the sale represents a partial liquidation rather than a wholesale de-risking.

CFO Jorge Celaya sells 17,565 shares at avg $30.21; all 3 prior LQDT sales were 90d well-timed.

Celaya executed 2 separate open-market sales totaling 17,565 shares (17.6K) for $530,601.87 ($530.6K) on 2025-11-26 and 2025-12-01, reducing his holdings by 33.9%. This marks his 4th sale at LQDT within the past year. His prior 3 sales at this ticker all produced negative 90-day returns (-29.6%, -25.5%, -12.5%), achieving a 100% well-timed rate at this specific ticker. His cross-ticker track record shows a 100% well-timed rate across 3 prior sells with an average 90d return of -22.5%, indicating a consistent pattern of selling before declines. The stock currently trades at $29.84, down 20.7% from its 52-week high of $37.61, suggesting the recent sales occurred closer to recent strength (+24.6% gain in the last 30 days, +14.2% in 90 days). The company's fundamentals remain solid with +31.2% annual revenue growth and a market cap of $914.3M, but the insider's demonstrated ability to time exits before subsequent weakness is a notable signal.

CFO Celaya Jorge sold 17,500 shares across 2 sales (Feb 10–12) at blended $34.71; reduces stake -39.1% to 27.3K shares held.

Celaya Jorge (EVP & Chief Financial Officer) executed 2 separate sales totaling 17,500 shares for $607,475.00 between February 10–12, 2025, at prices ranging from $34.25 to $35.33. The transaction reduces his holdings by 39.1% (from 44,775 to 27,275 shares), representing a material reduction in his ownership stake at a time when LQDT has demonstrated strong recent momentum: the stock is up +42.1% over 90 days and +7.2% over 30 days, currently trading at $35.55 (within 5.5% of its 52-week high of $37.61). The company's underlying fundamentals show solid growth with annual revenue increasing 15.5% to $122.3M quarterly revenue and net income of $5.8M, though the P/E of 46.17 reflects an elevated valuation. The scale and timing of this sale—a significant portfolio reduction coinciding with elevated stock prices following a strong recent run—merit attention alongside the company's stretched valuation metrics.

CFO Celaya sold 16,540 shares of LQDT at $34.10 on 2024-12-16, retaining 33,608 shares post-sale

Celaya Jorge, EVP & Chief Financial Officer, sold 16,540 shares for $564,014.00, reducing his holdings by 33.0% from 50,148 shares. The transaction occurred at $34.10 per share, which is 9.4% above the current price of $31.10 but 4.0% below the 52-week high of $35.54. The company's current P/E ratio of 50.16 reflects a significantly elevated valuation relative to profitability ($6.0M net income on $93.6M quarterly revenue), despite the stock's strong recent momentum (+22.7% over 30 days, +33.2% over 90 days). The CFO retains substantial equity ownership at 33,608 shares post-transaction, indicating continued material exposure to the company's performance, though the magnitude of the reduction warrants investor attention to any signaled adjustments in management's capital allocation or confidence levels.